Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,969
Total Claims
$1.2M
Drug Cost
700
Beneficiaries
$1,678
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-10%
Opioid rate vs peers
2.3% vs 2.6% avg
+57%
Cost per patient vs peers
$1,678 vs $1,068 avg
+65%
Brand preference vs peers
14.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.3%
Opioid Rate
324
Opioid Claims
$6,120
Opioid Cost
4.3%
Long-Acting Rate
Brand vs Generic
Brand: 2,057 claims · $943K
Generic: 11,796 claims · $226K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 157 | $163K |
| Apixaban | 154 | $94K |
| Fluticasone/Umeclidin/Vilanter | 86 | $87K |
| Semaglutide | 68 | $72K |
| Empagliflozin | 52 | $54K |
| Sitagliptin Phosphate | 65 | $42K |
| Rivaroxaban | 67 | $41K |
| Dapagliflozin Propanediol | 23 | $29K |
| Mirabegron | 67 | $26K |
| Fluticasone/Vilanterol | 48 | $23K |
| Tirzepatide | 20 | $22K |
| Linaclotide | 15 | $20K |
| Budesonide/Formoterol Fumarate | 35 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 20 | $16K |
| Insulin Aspart Prot/Insuln Asp | 18 | $15K |
Prescribing Profile
Patient Profile
74
Avg Age
73%
Female
1.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About